Connect with us

New Jersey

Chrissy Buteas: Saving lives around the world by finding cures in New Jersey – New Jersey Globe

Published

on

Chrissy Buteas: Saving lives around the world by finding cures in New Jersey – New Jersey Globe


OPINION

New Jersey – home to the Sopranos, the Jersey Shore, full-service gas stations and the long-running debate over pork roll versus Taylor ham.  Gritty, smart as hell, and loyal to our Jets . . . or Giants . . . or Eagles – that’s Jersey.  As a proud New Jersey native, I’ve fiercely defended our great state to those interlopers who criticize us as merely “that place between New York and Philly” (but with better beaches).

New Jersey is so much more than the memes and tropes that fly around the internet.  Often overlooked is the fact that for nearly 150 years, New Jersey has been one of the most important places on Earth when it comes to saving lives and improving the quality of life for patients, families and our loved ones all over the world.

Our long, proud and storied (but often unrecognized) history of leading the world stretches from Thomas Edison opening his laboratory in Menlo Park in 1876, to Johnson & Johnson establishing itself in New Brunswick in 1886, to Bell Labs opening its headquarters in Murray Hill in 1967.  The advances resulting from such a research-oriented state include the first steam locomotive to actually pull a train, the world’s first submarine, first light bulb, first movie, and even the first brewery in America.

Advertisement

The crown jewel of these transformative contributions – the one that also serves as the beating heart of New Jersey’s workforce and economy is our vibrant and robust life sciences ecosystem.  Our state’s medical technology, biotech, diagnostic, pharmaceutical and medical device companies have been at the forefront of cutting-edge medical innovations that have transformed global health, helping patients live longer, with less pain, with more independence while enjoying a greater quality of life.  These companies are the envy of our neighbors.  Rarely does a week go by without states like Pennsylvania or California, or other countries like Singapore or Ireland, trying to lure the operations of these great companies away from the Garden State.

These and other life sciences companies have driven breathtaking advances in medicine that have delivered new treatments and cures for some of the world’s most dreaded diseases.  For the first time in human history, we have cured hepatitis C – the days of liver transplants and life-long treatments are over.  We now have a simple vaccine that prevents cervical cancer, something unheard of less than two decades ago.  HIV/AIDS has become a chronic, manageable condition instead of the death sentence it once was.  A few years ago, we saw the first-ever Ebola vaccine – a life-saving advance for millions of people in Africa and around the world – followed a few years later by a vaccine (and diagnostics and treatments) for COVID-19 as well as the first-ever treatment to delay the onset of Alzheimer’s.

These are merely some of the latest extraordinary breakthroughs in health care these companies work so hard to discover.  New Jersey’s life sciences companies are working at breakneck speed to discover new treatments and cures for diabetes, any one of 7,000 rare diseases such as Pompe disease and Non-Hodgkin lymphoma, many types of cancer, and a vaccine against HIV/AIDS.  Drug discovery is a highly risky and costly proposition, with only one out of every 5,000 researched compounds making it to market after a 10-to-15-year development process at an average cost of $2.6 billion.  However, recent successes and cutting-edge advances in research and technology signify that we’re on the cusp of even more astounding medical progress than was imaginable even a few short years ago.

Recently, I became the new President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), a trade association representing the New Jersey companies that are working so hard to research and discover the next generation of treatments and cures.  Our mission – and one that I am immensely proud to help champion – is to ensure that New Jersey and our life sciences community continues to do what we’ve done so extraordinarily well for over a century – help patients around the world by finding cures here in New Jersey.

 

Advertisement



Source link

New Jersey

NJ’s new budget is coming. How will state finances affect your taxes?

Published

on

NJ’s new budget is coming. How will state finances affect your taxes?



3-minute read

play

Gov. Mikie Sherrill is set to present her first state budget proposal in a Tuesday, March 10, address to the New Jersey Legislature. It’s clear the proposal will make some hard choices as state finances face major headwinds.

Late last month, Sherrill said her budget plan will include some “tough choices” because of the looming uncertainty of a structural deficit for state finances.

The governor explained that if projections stay on the current path, the state would have a structural deficit of about $3 billion by the end of June, when her proposed budget would be in the final stages of negotiations with the Legislature.

Uncertainty due to federal funding cuts, along with the end of pandemic relief funding, has already forced Sherrill to consider all of her options when crafting her plan for New Jersey’s fiscal year 2027.

Advertisement

The governor wouldn’t give particulars about what to expect in her upcoming fiscal plan but instead said she is “setting the table so people can anticipate that this is going to be a tough budget season.”

What does a structural deficit mean for New Jersey taxpayers?

A structural deficit, simply put, means New Jersey spends more than it earns.

Among the costliest tax relief programs in the state’s history, Stay NJ was introduced legislatively in the run-up to the fiscal year 2024 budget and received funding for three years without paying anything out.

Advertisement

The first Stay NJ checks are being sent out to qualifying New Jersey seniors, but the accumulated $1.2 billion covers only the first six months of the program for this year. Roughly $900 million will need to be added to the line item in Sherrill’s first fiscal plan to maintain the program.

The law that created Stay NJ requires full pension payments, full school funding payments and a surplus of at least 12% to be built into the budget as prerequisites for funding the program. The surplus was not 12% when the budget was signed during the last two years, but budget language allowed for a work-around.

Sherrill would not commit to requiring the prerequisites before she would be willing to sign a budget bill in late June.

Increasing costs for the State Health Benefits Program, which is already a contentious topic, could also be a concern for the new governor, as payments are about $2 billion annually and the 10% increase needed in this year’s budget added more than $180 million.

Advertisement

How does New Jersey’s budget process work?

New Jersey’s $58.8 billion budget for fiscal year 2026 is the largest in history and is set to expire at the end of June.

The plan for fiscal year 2027 — which will run from July 1, 2026, through June 30, 2027 — is a major factor in how New Jersey state government will function by dictating which state departments and programs are funded.

After Sherrill’s address in March, her proposed spending and revenue plan will be analyzed and shaped in the Legislature through the spring. Negotiations will heat up as the current fiscal year winds to a close in June. If the budget cycle is normal, a final budget bill will land on Sherrill’s desk hours before the current fiscal year ends at 11:59 p.m. on June 30.

Though it would be unlikely — given Democratic control of both chambers of the Legislature and the governor’s office — in the event the budget bill does not get signed, state government shuts down. There have been two shutdowns in state history: for 10 days in 2006 and three days in 2017.

Katie Sobko covers the New Jersey Statehouse. Email: sobko@northjersey.com

Advertisement



Source link

Continue Reading

New Jersey

Woman fatally struck by NJ Transit train in Ramsey

Published

on

Woman fatally struck by NJ Transit train in Ramsey


play

A woman was fatally struck by a train in Ramsey on the morning of March 8.

The unidentified woman was hit by the train at 10:49 a.m., just west of the Main Street crossing near the main Ramsey station, said John Chartier, director of media relations for NJ Transit.

Advertisement

Rail service was suspended in both directions between Allendale and Port Jervis but has since resumed, with delays of up to 30 minutes.

The train came from Port Jervis and was heading to Hoboken, and 150 people were on board at the time, Chartier said.

NJ Transit police are leading the investigation. No additional information about the circumstances of the death was available.



Source link

Advertisement
Continue Reading

New Jersey

Bratt | POST-RAW 3.7.26 | New Jersey Devils

Published

on

Bratt | POST-RAW 3.7.26 | New Jersey Devils


NewJerseyDevils.com is the official web site of the New Jersey Devils, a member team of the National Hockey League (“NHL”). NHL, the NHL Shield, the word mark and image of the Stanley Cup and NHL Conference logos are registered trademarks of the National Hockey League. All NHL logos and marks and NHL team logos and marks as well as all other proprietary materials depicted herein are the property of the NHL and the respective NHL teams and may not be reproduced without the prior written consent of NHL Enterprises, L.P. Copyright © 1999-2025 New Jersey Devils and the National Hockey League. All Rights Reserved.



Source link

Continue Reading

Trending